| Inventor | Institute |
|---|---|
| Bernhard Singer | Leukocom GmbH |
| Product description: | CEACAM is a glycoprotein involved in cell adhesion and intracellular signaling. It is normally produced during fetal development in the gut, and its production stops before birth. CEA is re-expressed in increased amounts in Intestinal Carcinomas and several other tumors. |
|---|---|
| Alternate name: | Anti human CEACAM5/8 (CD66e/b) |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Molecular weight: | 180 kDa (huCEACAM5); 38 kDa (huCEACAM8) |
| Immunogen: | Supernatant of a CEA-expressing human cell-line |
| Cat. #: | 162453 |
|---|---|
| Tool sub type: | Primary antibody |
| Research Fields: | Immunology |
| Application: | Flow Cytometry, ELISA, IF, IP, WB |
| Target: | Binds specifically to human CEACAM5 and CEACAM8 (CD66a/b). |
| Reactivity: | Human |
| Clone: | P1-1F-9D |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Zi-Wen Han et al. (2020) Investigational New Drug 38(6):1888-1898 |
| Storage buffer: | PBS with 0.02% azide |
|---|---|
| Shipping conditions: | Dry ice |
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.